Cargando…
The effect of subcutaneous methotrexate on markers of metabolic syndrome in psoriatic patients – preliminary report
INTRODUCTION: Methotrexate (MTX) has anti-proliferative and anti-inflammatory effects in psoriasis. Moreover, low doses can reduce the risk of developing cardiovascular diseases. It turns out that psoriasis and atherosclerosis have a similar pathogenetic mechanism: the same pro-inflammatory cytokine...
Autores principales: | Owczarczyk-Saczonek, Agnieszka, Drozdowski, Marek, Maciejewska-Radomska, Agata, Choszcz, Dariusz, Placek, Waldemar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5872240/ https://www.ncbi.nlm.nih.gov/pubmed/29599672 http://dx.doi.org/10.5114/ada.2017.71358 |
Ejemplares similares
-
Fatigue – an underestimated symptom in psoriatic arthritis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2017) -
Sleep disorders in patients with psoriatic arthritis and psoriasis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2018) -
Prevalence and severity of fatigue in psoriasis and psoriatic arthritis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2020) -
The Effect of the Long-Term Calcipotriol/Betamethasone Dipropionate Local Therapy on Tissue Resident Memory Cells Markers in Psoriatic Eruptions
por: Kasprowicz-Furmańczyk, Marta, et al.
Publicado: (2022) -
Changes in body composition and bone mineral density in postmenopausal women with psoriatic arthritis
por: Krajewska-Włodarczyk, Magdalena, et al.
Publicado: (2017)